456 related articles for article (PubMed ID: 34012921)
1. Escape From Treatment; the Different Faces of Leukemic Stem Cells and Therapy Resistance in Acute Myeloid Leukemia.
van Gils N; Denkers F; Smit L
Front Oncol; 2021; 11():659253. PubMed ID: 34012921
[TBL] [Abstract][Full Text] [Related]
2. Targeting histone methylation to reprogram the transcriptional state that drives survival of drug-tolerant myeloid leukemia persisters.
van Gils N; Verhagen HJMP; Broux M; Martiáñez T; Denkers F; Vermue E; Rutten A; Csikós T; Demeyer S; Çil M; Al M; Cools J; Janssen JJWM; Ossenkoppele GJ; Menezes RX; Smit L
iScience; 2022 Sep; 25(9):105013. PubMed ID: 36097617
[TBL] [Abstract][Full Text] [Related]
3. Specific Depletion of Leukemic Stem Cells: Can MicroRNAs Make the Difference?
Martiáñez Canales T; de Leeuw DC; Vermue E; Ossenkoppele GJ; Smit L
Cancers (Basel); 2017 Jun; 9(7):. PubMed ID: 28665351
[TBL] [Abstract][Full Text] [Related]
4. Acute Myeloid Leukemia Stem Cells in Minimal/Measurable Residual Disease Detection.
Srinivasan Rajsri K; Roy N; Chakraborty S
Cancers (Basel); 2023 May; 15(10):. PubMed ID: 37345204
[TBL] [Abstract][Full Text] [Related]
5. Convergent epigenetic evolution drives relapse in acute myeloid leukemia.
Nuno K; Azizi A; Koehnke T; Lareau C; Ediriwickrema A; Corces MR; Satpathy AT; Majeti R
Elife; 2024 Apr; 13():. PubMed ID: 38647535
[TBL] [Abstract][Full Text] [Related]
6. MRD in Venetoclax-Based Treatment for AML: Does it Really Matter?
Bernardi M; Ferrara F; Carrabba MG; Mastaglio S; Lorentino F; Vago L; Ciceri F
Front Oncol; 2022; 12():890871. PubMed ID: 35924144
[TBL] [Abstract][Full Text] [Related]
7. Characteristics of leukemic stem cells in acute leukemia and potential targeted therapies for their specific eradication.
Hansen Q; Bachas C; Smit L; Cloos J
Cancer Drug Resist; 2022; 5(2):344-367. PubMed ID: 35800375
[TBL] [Abstract][Full Text] [Related]
8. A Leukemic Target with a Thousand Faces: The Mitochondria.
Maffeo B; Panuzzo C; Moraca A; Cilloni D
Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37685874
[TBL] [Abstract][Full Text] [Related]
9. Leukemic stem cells and therapy resistance in acute myeloid leukemia.
Stelmach P; Trumpp A
Haematologica; 2023 Feb; 108(2):353-366. PubMed ID: 36722405
[TBL] [Abstract][Full Text] [Related]
10. Molecular patterns of response and treatment failure after frontline venetoclax combinations in older patients with AML.
DiNardo CD; Tiong IS; Quaglieri A; MacRaild S; Loghavi S; Brown FC; Thijssen R; Pomilio G; Ivey A; Salmon JM; Glytsou C; Fleming SA; Zhang Q; Ma H; Patel KP; Kornblau SM; Xu Z; Chua CC; Chen X; Blombery P; Flensburg C; Cummings N; Aifantis I; Kantarjian H; Huang DCS; Roberts AW; Majewski IJ; Konopleva M; Wei AH
Blood; 2020 Mar; 135(11):791-803. PubMed ID: 31932844
[TBL] [Abstract][Full Text] [Related]
11. Jiyuan oridonin A induces differentiation of acute myeloid leukemia cells including leukemic stem-like cells.
Li F; Gao C; Li X; Wang J; Zhao Y; Ke Y; Liu Y; Liu HM; Hu Z; Wei L; Chen ZS
Front Pharmacol; 2022; 13():1001552. PubMed ID: 36133825
[TBL] [Abstract][Full Text] [Related]
12. Measurable Residual Disease in High-Risk Acute Myeloid Leukemia.
Cluzeau T; Lemoli RM; McCloskey J; Cooper T
Cancers (Basel); 2022 Mar; 14(5):. PubMed ID: 35267586
[TBL] [Abstract][Full Text] [Related]
13. Drug Resistance Mechanisms of Acute Myeloid Leukemia Stem Cells.
Niu J; Peng D; Liu L
Front Oncol; 2022; 12():896426. PubMed ID: 35865470
[TBL] [Abstract][Full Text] [Related]
14. The pan-Bcl2 Inhibitor AT101 Activates the Intrinsic Apoptotic Pathway and Causes DNA Damage in Acute Myeloid Leukemia Stem-Like Cells.
Zhang L; Zhou Y; Chen K; Shi P; Li Y; Deng M; Jiang Z; Wang X; Li P; Xu B
Target Oncol; 2017 Oct; 12(5):677-687. PubMed ID: 28710745
[TBL] [Abstract][Full Text] [Related]
15. Transplant characteristics: minimal residual disease and impaired megakaryocytic colony growth as sensitive parameters for predicting relapse in acute myeloid leukemia.
Reichle A; Rothe G; Krause S; Zaiss M; Ullrich H; Schmitz G; Andreesen R
Leukemia; 1999 Aug; 13(8):1227-34. PubMed ID: 10450751
[TBL] [Abstract][Full Text] [Related]
16. Evolving Therapies in Acute Myeloid Leukemia: Progress at Last?
DeAngelo DJ; Stein EM; Ravandi F
Am Soc Clin Oncol Educ Book; 2016; 35():e302-12. PubMed ID: 27249736
[TBL] [Abstract][Full Text] [Related]
17. Single-Cell Gene Expression Analyses Reveal Distinct Self-Renewing and Proliferating Subsets in the Leukemia Stem Cell Compartment in Acute Myeloid Leukemia.
Sachs K; Sarver AL; Noble-Orcutt KE; LaRue RS; Antony ML; Chang D; Lee Y; Navis CM; Hillesheim AL; Nykaza IR; Ha NA; Hansen CJ; Karadag FK; Bergerson RJ; Verneris MR; Meredith MM; Schomaker ML; Linden MA; Myers CL; Largaespada DA; Sachs Z
Cancer Res; 2020 Feb; 80(3):458-470. PubMed ID: 31784425
[TBL] [Abstract][Full Text] [Related]
18. Antibody-Targeted Cyclodextrin-Based Nanoparticles for siRNA Delivery in the Treatment of Acute Myeloid Leukemia: Physicochemical Characteristics, in Vitro Mechanistic Studies, and ex Vivo Patient Derived Therapeutic Efficacy.
Guo J; Russell EG; Darcy R; Cotter TG; McKenna SL; Cahill MR; O'Driscoll CM
Mol Pharm; 2017 Mar; 14(3):940-952. PubMed ID: 28146632
[TBL] [Abstract][Full Text] [Related]
19. Immunophenotyping investigation of minimal residual disease is a useful approach for predicting relapse in acute myeloid leukemia patients.
San Miguel JF; Martínez A; Macedo A; Vidriales MB; López-Berges C; González M; Caballero D; García-Marcos MA; Ramos F; Fernández-Calvo J; Calmuntia MJ; Diaz-Mediavilla J; Orfao A
Blood; 1997 Sep; 90(6):2465-70. PubMed ID: 9310499
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia.
Cloos J; Harris JR; Janssen JJWM; Kelder A; Huang F; Sijm G; Vonk M; Snel AN; Scheick JR; Scholten WJ; Carbaat-Ham J; Veldhuizen D; Hanekamp D; Oussoren-Brockhoff YJM; Kaspers GJL; Schuurhuis GJ; Sasser AK; Ossenkoppele G
J Vis Exp; 2018 Mar; (133):. PubMed ID: 29553571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]